P2RX7 and neoplasm: CD39 blockade has been shown to reduce tumor growth not only because of the diminished generation of downstream adenosine (see below) but also by enhanced P2X7-mediated NRLP3 inflammasome due to extracellular accumulation of ATP (Li et al., 2019; Baeza-Raja et al., 2020).